Brussels, 09/02/2016 (Agence Europe) - The majority of medicines marketed in the European Union will have to contain a security mechanism proving their authenticity as from 2019. This is stipulated in a delegated regulation published on Tuesday 9 February in the European Union's Official Journal.
Falsifiers are false medicinal products that have been authorised as authentic medicines. Given that they have not been subject to quality assessment procedures on safety and efficiency, as...